Clinical trial for monkeypox medication starts in the Democratic Republic of the Congo
A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. www.nih.gov/news-events/news-releases/monkeypox-treatment-trial-begins-democratic-republic-congo? The National Institute of Allergy […]
Clinical trial for monkeypox medication starts in the Democratic Republic of the Congo Read More »